about
Hepatocellular carcinoma: epidemiology, biology, diagnosis, and therapiesTargeting Hepatocellular Carcinoma: What did we Discover so Far?Perioperative tumor cell dissemination in patients with primary or metastatic colorectal cancer.MIA PaCa-2 and PANC-1 - pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors.Histologic evaluation of the effect of mineral trioxide aggregate-Fillapex as a root canal sealer in rat teeth submitted to late replantation.The role of vitamins in cancer: a review.Amniotic membrane: from structure and functions to clinical applications.Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose.Retinoblastoma: might photodynamic therapy be an option?Bisphosphonate-related osteonecrosis of the jaw: specificities.Lung cancer: the immune system and radiation.Clinical translation for endometrial cancer stem cells hypothesis.Revisit dietary fiber on colorectal cancer: butyrate and its role on prevention and treatment.Quercetin in Cancer Treatment, Alone or in Combination with Conventional Therapeutics?The importance of radiotherapy on diffuse large B cell lymphoma treatment: a current review.Cholangiocarcinoma: from molecular biology to treatment.The role of immune system exhaustion on cancer cell escape and anti-tumor immune induction after irradiation.Combined dual effect of modulation of human neutrophils' oxidative burst and inhibition of colon cancer cells proliferation by hydroxycinnamic acid derivatives.Ascorbic acid and colon cancer: an oxidative stimulus to cell death depending on cell profile.Oxidative Stress, DNA, Cell Cycle/Cell Cycle Associated Proteins and Multidrug Resistance Proteins: Targets of Human Amniotic Membrane in Hepatocellular Carcinoma.New Approach for Treatment of Primary Liver Tumors: The Role of Quercetin.Effects of X-radiation on lung cancer cells: the interplay between oxidative stress and P53 levels.Influence of P53 on the radiotherapy response of hepatocellular carcinoma.Selective cytotoxicity and cell death induced by human amniotic membrane in hepatocellular carcinoma.Novel 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine fused chlorins as very active photodynamic agents for melanoma cells.Liver diseases: what is known so far about the therapy with human amniotic membrane?Metabolic effects of hypoxia in colorectal cancer by 13C NMR isotopomer analysis.Targeting triple-negative breast cancer cells with 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles.Evaluation of a (99m) Tc-labelled meso-bisphenylporphyrin as a tumour image agent.Effect of amniotic membrane proteins in human cancer cell lines: an exploratory study.Microenvironment influence on human colon adenocarcinoma phenotypes and matrix metalloproteinase-2, p53 and β-catenin tumor expressions from identical monoclonal cell tumor in the orthotopic model in athymic nude rats.Beyond the limits of oxygen: effects of hypoxia in a hormone-independent prostate cancer cell line.2-Bromo-5-hydroxyphenylporphyrins for photodynamic therapy: photosensitization efficiency, subcellular localization and in vivo studies.Hepatocellular carcinoma and chemotherapy: the role of p53.Cytotoxicity of ascorbic acid in a human colorectal adenocarcinoma cell line (WiDr): in vitro and in vivo studies.Effect of miR-34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines.Synthesis of new 2-galactosylthiazolidine-4-carboxylic acid amides. Antitumor evaluation against melanoma and breast cancer cells.99mTc(I)/Re(I) tricarbonyl complexes for in vivo targeting of melanotic melanoma: Synthesis and biological evaluation.Radiolabelling of ascorbic acid: a new clue to clarify its action as an anticancer agent?Chiral 6-hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: novel antitumor DNA monoalkylating agents.
P50
Q27026025-E2D224EB-7351-4A2B-8B8E-A77468E8137DQ28077283-C737F6CA-71FD-4A58-ACA6-4BFA15D73A90Q33489148-F72D3DC6-2665-4CB2-9E14-519F350BA720Q36588574-8401FAB1-0E62-4FD1-8874-E1BA579B2D81Q37736963-2822A266-4BEF-48DF-ADCF-24B64A2D017CQ37871939-5114CA4B-C73B-4E61-976E-13083B147171Q38010638-D7B2B8E2-CACD-431D-9C60-B144E6BA5491Q38213800-A6C9D424-7EF2-4EE5-A5FC-7CBDCD81CD0AQ38314528-BCA3688D-9C97-4BCF-AD57-57E6EE8DB32BQ38493204-FDB39E0E-D85C-4D5B-8B92-58D837F9683FQ38540827-CD8CAFAF-5BBF-4268-AA10-1FED3165AF17Q38557171-1A66CAE5-F51F-42AB-99ED-31D3D002C05FQ38557172-F9C570D9-4BE2-4D47-8AAC-743AFF92DFFEQ38564818-849846E3-E735-4E63-802D-B543C7970CDBQ38565503-9796D8A0-8BA8-4C21-B37E-4EC80C636FCAQ38597008-06F8A7A8-BC02-4F09-A226-2A2F932E0E2CQ38730343-16D7A800-1BBC-4371-816A-0EB59A655550Q38764940-740CF8D3-63AC-46B7-9F5A-1581B81197D7Q38777806-D1EAD1BA-3AD3-4F20-A5CA-DD306E80D239Q38787238-1132E640-1CF2-4337-94EE-091C4A8BC24CQ38788907-50E26E6E-DCEB-4C10-A106-E0C973C3F058Q38818565-3FFA3EC9-29B7-45A7-A699-645998A8D552Q38822712-C560DFBA-3431-4CB9-86AB-AD49F485FD03Q38824357-4AA994D3-D742-4DF4-B097-C51E8CA47B11Q38834482-3CC04CC7-DD67-4667-8CD8-9113876106B4Q38934348-641A12F7-6C76-4F67-A144-483435745DB9Q38968639-563E82E6-52E2-42A2-874E-EB52895E6639Q39002877-E42610CB-E1DB-4C9A-94EC-E0AD70C9BE45Q39014906-8456A0D5-6F5E-45B4-88A6-958A4678CF46Q39020188-D8A101AE-A24D-4CAD-A264-EC43DB1241DAQ39044766-ADD7BBE8-5CCC-4E70-AD9A-FADB6464825EQ39069174-7493D1D2-C690-47A1-BB95-21B93961C68FQ39184734-CA08238A-965A-4A57-A47F-3253CDB76FFAQ39222765-91C9D974-B83F-4A2C-B005-12A9ACA8643AQ39279729-F79246D2-3FC9-4F1A-934F-13ABC63EEAA1Q39346975-DD2C684E-6932-4514-9E8A-CA20F51C55A3Q39353511-A7F4989F-BBFE-4354-A583-3A27765E5C32Q39383884-545240A0-EBD6-4D51-8F67-6A2A421953D7Q39405869-DB8C5A42-B4F4-4785-BBE4-98DC1F9BBEA1Q39668177-CF80B594-8BBE-401D-9E4E-5A36943713EE
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Maria Filomena Botelho
@ast
Maria Filomena Botelho
@en
Maria Filomena Botelho
@es
Maria Filomena Botelho
@nl
Maria Filomena Botelho
@sl
type
label
Maria Filomena Botelho
@ast
Maria Filomena Botelho
@en
Maria Filomena Botelho
@es
Maria Filomena Botelho
@nl
Maria Filomena Botelho
@sl
altLabel
F Botelho
@en
MF Botelho
@en
prefLabel
Maria Filomena Botelho
@ast
Maria Filomena Botelho
@en
Maria Filomena Botelho
@es
Maria Filomena Botelho
@nl
Maria Filomena Botelho
@sl
P214
P1053
G-1860-2011
P106
P1153
7005751167
P21
P214
P31
P3829
P496
0000-0001-7202-1650
P735
P7859
viaf-99941309